Rheumatoid Arthritis Biospecimens
Rheumatoid arthritis is a chronic autoimmune disorder caused by the dysregulation of humoral and cell-mediated immunity, though its precise origins remain unknown. The disease prompts the production of anti-rheumatoid factor antibodies that target and attack the body's joints. Millions of people across the globe are affected by this type of inflammatory arthritis.
Rheumatoid arthritis typically affects the lining of joints, leading to significant swelling and inflammation. This can cause the degradation of bone, the deterioration of synovial joints, and structural abnormalities. Patients with rheumatoid arthritis often experience difficulties with daily activities such as walking, sitting, standing, and running due to the chronic joint pain and stiffness caused by this debilitating condition. Additionally, women are more prone to inheriting rheumatoid arthritis compared to men, especially if there is a family history of the disease.
If left untreated or poorly managed, acute rheumatoid arthritis can quickly develop into a chronic form of the disease, resulting in severe disability, accelerated aging, and even early death. Beyond physical pain, rheumatoid arthritis negatively impacts patients' social, emotional, and psychological well-being.
Rheumatoid Arthritis Biospecimens at Your Reach: Visit Centrallink
Centrallink provides unparalleled access to
rheumatoid arthritis biospecimens to support groundbreaking research and improve the understanding of this disease. With a collection of over 18,000 high-quality
human biospecimens sourced from patients exhibiting symptoms of rheumatoid arthritis, Centrallink leads the charge in facilitating continuous research aimed at improving diagnosis, treatment, and overall quality of life for patients affected by this autoimmune condition.
Discover Over 10,000 Serum and Plasma Samples from Rheumatoid Arthritis Patients
Centrallink offers an extensive range of
rheumatoid arthritis biospecimens, including
serum and
plasma samples, each annotated with a comprehensive clinical data profile. This data includes critical information about drug therapies, patient demographics (such as age, gender, and ethnicity), and whether the samples are from newly diagnosed or chronic arthritis patients. Our
rheumatoid arthritis biospecimens are precisely screened for essential biomarkers, such as:
- Rheumatoid factor antibody (RF) or RA factor
- Erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
- Anti-citrullinated protein/peptide antibodies (ACPA/anti-CCP), also known as rheumatoid autoantibodies
These biomarkers are vital for understanding the disease’s progression, helping researchers identify novel diagnostic and therapeutic targets for improving rheumatoid arthritis treatment.
Why Choose Centrallink for Rheumatoid Arthritis Biospecimens?
Centrallink ensures a simple and efficient process for ordering high-quality
rheumatoid arthritis biospecimens, supported by immediate shipment and full customer assistance throughout the procurement process. Our platform provides researchers with reliable, well-annotated samples that meet the highest standards, enabling breakthrough research in rheumatoid arthritis and supporting efforts to develop innovative treatments.
Get Started Today
Explore the world's largest collection of
rheumatoid arthritis biospecimens at Centrallink. Whether you are focused on diagnostics, therapy development, or disease understanding, our biospecimens are the key to advancing your research. Visit Centrallink today for easy ordering and fast, reliable delivery.